Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Annexon is a US-based biopharmaceutical company specializing in the development of novel therapies to treat complement-mediated diseases. The company focuses on blocking the classical complement pathway to advance potential treatments for patients suffering from devastating neurological disorders.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Annexon is scheduled to report its next quarterly earnings on 11/16/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Annexon last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at -0.28 USD.
Annexon has beaten analyst EPS estimates in 4 of its last 6 evaluated quarters (beat rate: 66.7%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.